CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $433 | -19.2% | 9,550 | 0.0% | 0.04% | -14.6% |
| Q2 2023 | $536 | +24.1% | 9,550 | 0.0% | 0.04% | +17.1% |
| Q1 2023 | $432 | +11.3% | 9,550 | 0.0% | 0.04% | +9.4% |
| Q4 2022 | $388 | -99.9% | 9,550 | 0.0% | 0.03% | -41.8% |
| Q3 2022 | $624,000 | +7.6% | 9,550 | 0.0% | 0.06% | +14.6% |
| Q2 2022 | $580,000 | -3.2% | 9,550 | 0.0% | 0.05% | +11.6% |
| Q1 2022 | $599,000 | -17.3% | 9,550 | 0.0% | 0.04% | -8.5% |
| Q4 2021 | $724,000 | -32.3% | 9,550 | 0.0% | 0.05% | -39.0% |
| Q3 2021 | $1,069,000 | -30.9% | 9,550 | 0.0% | 0.08% | -30.0% |
| Q2 2021 | $1,546,000 | +32.9% | 9,550 | 0.0% | 0.11% | +26.4% |
| Q1 2021 | $1,163,000 | -26.3% | 9,550 | -7.3% | 0.09% | -28.1% |
| Q4 2020 | $1,577,000 | +83.2% | 10,300 | 0.0% | 0.12% | +55.1% |
| Q3 2020 | $861,000 | +13.7% | 10,300 | 0.0% | 0.08% | +5.4% |
| Q2 2020 | $757,000 | +73.2% | 10,300 | 0.0% | 0.07% | +42.3% |
| Q1 2020 | $437,000 | -30.3% | 10,300 | 0.0% | 0.05% | -13.3% |
| Q4 2019 | $627,000 | +47.2% | 10,300 | -1.0% | 0.06% | +36.4% |
| Q3 2019 | $426,000 | -13.1% | 10,400 | 0.0% | 0.04% | -13.7% |
| Q2 2019 | $490,000 | +32.1% | 10,400 | 0.0% | 0.05% | +27.5% |
| Q1 2019 | $371,000 | +24.9% | 10,400 | 0.0% | 0.04% | +8.1% |
| Q4 2018 | $297,000 | -36.3% | 10,400 | -1.0% | 0.04% | -24.5% |
| Q3 2018 | $466,000 | -23.7% | 10,500 | +1.0% | 0.05% | -29.0% |
| Q2 2018 | $611,000 | +33.7% | 10,400 | +4.0% | 0.07% | +32.7% |
| Q1 2018 | $457,000 | – | 10,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |